戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 pression, and in 2005, the agency mandated a black box warning and medication guide indicating that p
2   Forty-five drugs (8.2%) acquired 1 or more black box warnings and 16 (2.9%) were withdrawn from the
3 hilic species is responsible for over 60% of black box warnings and drug withdrawals from the market
4 ostic testing, the current status of the ECA Black Box Warning, and recommended safety precautions du
5 loride, even though it carries the same FDA "black box" warning as the selective serotonin reuptake i
6 te drug safety and to examine the droperidol black-box warning as a case study.
7 es Food and Drug Administration has issued a black box warning asking providers to use caution when p
8               All nucleoside analogs have a "Black Box" warning because of their potential for inhibi
9  were withdrawn from marketing or received a black-box warning because of hepatotoxicity were prescri
10 avior, and in October 2004, the FDA issued a black box warning concerning all antidepressants for you
11                                            A black box warning describes a potential risk of malignan
12                                          The black box warning for the use of maintenance ASA doses >
13        Food and Drug Administration issued a black box warning for varenicline regarding neuropsychia
14 d Drug Administration (FDA) announced a new "black box" warning for the perflutren-containing ultraso
15 ies report that there is no basis to issue a black-box warning for perioperative administration of dr
16  treatment of adolescent depression, and the black box warning from the United States Food and Drug A
17                                              Black-box warnings, generic availability of atorvastatin
18                           The paroxetine and black box warnings had modest and relatively targeted ef
19          The association is highlighted by a black-box warning issued by the US Food and Drug Adminis
20 ing (June 20, 2003 to October 15, 2004), and black box warning (October 16, 2004 to December 31, 2005
21  to 27.8), more likely to carry a subsequent black-box warning (odds ratio, 4.4; 95% CI, 1.2 to 20.5)
22  and suicidality but voted against placing a black box warning on AEDs for suicidality.
23 d and Drug Administration recently placed a "black box" warning on the ultrasound contrast agents Def
24    While the atypical antipsychotics have a 'black box warning' on risk of death in elderly patients
25                    The controversy over the 'black box warning' on the use of droperidol is discussed
26 the estimated probability of acquiring a new black box warning or being withdrawn from the market ove
27 oved in 1975-1999; 56 (10.2%) acquired a new black box warning or were withdrawn.
28 occurred including the addition of 1 or more black box warnings per drug, or drug withdrawal.
29 = .85), and more sharply declined during the black box warning period (rate, -0.27; 95% CI, -0.36 to
30                                       In the black box warning period, there was a small but signific
31 for all 3 antipsychotics declined during the black box warning period.
32 significant difference between the early and black box warning periods (P = .006).
33 equired a change in labeling that included a black box warning regarding SSRI use for all age groups.
34 advisory committee recommended that the 2004 black box warning regarding suicidality in pediatric pat
35                However, these agents carry a black box warning regarding their use during pregnancy d
36 per year (P = .21) during the paroxetine and black box warning study periods, respectively.
37 ates Food and Drug Administration use of the black-box warning system to promote drug safety and to e
38 eting safety problems (e.g., withdrawals and black-box warnings) than drugs approved at other times.
39                                Following the black box warning, the decline continued (rate, -0.26%;
40 nt, has a Food and Drug Administration (FDA) black box warning to avoid maintenance doses of aspirin
41 nd Drug Administration subjectively issued a black-box warning to droperidol, which effectively remov
42                                Postapproval, black box warnings were added to labels for four oncolog

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。